This report (https://doi.org/10.1245/s10434-023-14664- 0) shows interim data of a multicenter randomized controlled trial (RCT) comparing complete mesocolic excision (CME) versus right colectomy in patients with right colon cancer. After the enrollment of 258 patients, CME is documented to improve lymph node (LN) yield and quality of surgery, without increasing complications.
ASO Visual Abstract: A Randomized Phase III Trial of Complete Mesocolic Excision in Comparison with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-In Trial)
Azzolina D.;Baldazzi G.;Anania G.;Chiozza M.;Pizzini P.;
2024
Abstract
This report (https://doi.org/10.1245/s10434-023-14664- 0) shows interim data of a multicenter randomized controlled trial (RCT) comparing complete mesocolic excision (CME) versus right colectomy in patients with right colon cancer. After the enrollment of 258 patients, CME is documented to improve lymph node (LN) yield and quality of surgery, without increasing complications.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
